Granulocytic sarcoma of the ovotestis: An association of myelodysplastic syndrome and hermaphroditism

Leukemia and Lymphoma

Volumn 45, Issue 6, 2004, Pages 1285-1287

  Bolaman, Zahit ^a   Kadikoylu, Gurhan ^a   Kafkas, Samet ^a   Kacar, Firuzan ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Extramedullary disease; Granulocytic sarcoma; Hermaphroditism; Myelodysplastic syndrome; Ovotestis

Indexed keywords

CD33 ANTIGEN; CD68 ANTIGEN; CELL MARKER; CYTARABINE; DAUNORUBICIN; FOLLITROPIN; HEMOGLOBIN; LUTEINIZING HORMONE; MICROSOMAL AMINOPEPTIDASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BLAST CELL; BLOOD CELL; BLOOD SMEAR; BONE MARROW CELL; BONE MARROW EXAMINATION; BREAST DEVELOPMENT; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CELL INFILTRATION; CHROMOSOME ANALYSIS; CLITORIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; FOLLITROPIN BLOOD LEVEL; GENITAL SYSTEM EXAMINATION; GRANULOCYTIC SARCOMA; HEMOGLOBIN DETERMINATION; HEPATOSPLENOMEGALY; HERMAPHRODITISM; HISTOPATHOLOGY; HUMAN; HYPERTROPHY; HYPOPLASIA; IMMUNOHISTOCHEMISTRY; INGUINAL REGION; KARYOTYPE; LAPAROSCOPY; LEUKEMIA; LEUKOCYTE COUNT; LUTEINIZING HORMONE BLOOD LEVEL; MYELODYSPLASTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REFRACTORY ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION; THROMBOCYTE COUNT; UMBILICUS; VAGINA DISEASE; WEIGHT REDUCTION;

ADOLESCENT; BONE MARROW; CYTOGENETIC ANALYSIS; FATAL OUTCOME; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HERMAPHRODITISM; HUMANS; MALE; MYELODYSPLASTIC SYNDROMES; OVARIAN NEOPLASMS; SARCOMA, GRANULOCYTIC; TESTICULAR NEOPLASMS;

EID: 2342584052     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819032000159906     Document Type: Article

References (18)

1. Alessandrino, E.P., Amadori, S., Gioovanni, B., Cazolla, M., Grossi, A., Liberato, L.N., et al. (2002) "Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology", Haematologica, 87, 1286-1306.
2. Bennett, M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., et al. (1982) "Proposals for the classification of the myelodysplastic syndromes", Br. J. Haematol., 51, 189-199.
3. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K. and Vardiman, J. (1999) "World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997", J. Clin. Oncol., 17, 3835-3849.
4. Solé, F., Espinet, B., Sanz, G.F., Cervera, J., Calasanz, M.J., Luno, E., et al. (2000) "Incidence, characterisation and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes", Br. J. Haematol., 108, 346-356.
5. Mhawech, P. and Saleem, A. (2001) "Myelodysplastic syndrome: review of the cytogenetic and molecular data", Critic. Rev. Oncol/Hematol., 40, 229-238.
6. Hicsonmez, G., Cetin, M., Yenicesu, I., Olcay, L., Koc, A., Aktas, D., et al. (2001) "Evaluation of children with myelodysplastic syndrome: importance of extramedullary disease as a presenting symptom", Leuk. Lymphoma, 42, 665-674.
7. Sreejith, G., Gangadharan, V.P., Elizabath, K.A., Preetha, S. and Chithrathara, K. (2000) "Primary granulocytic sarcoma of the ovary", Am. J. Clin. Oncol., 23, 239-240.
8. Greenberg, P., Cox, C., LeBeau, M., Fenaux, P., Morel, P., Sanz, G., (1997) "International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes", Blood, 89, 2079-2086.
9. Foon, K. and Gale, R.P. (1992) "Therapy of acute myelogenous leukemia", Blood Rev., 6, 15-23.
10. Pisani, F.D. and Rainaldi, A. (2001) "Management of high-risk myelodysplastic syndromes", Critical Reviews in Oncology/Hematology, 40, 215-228.
11. Heaney, M.L. and Golde, D.W. (1999) "Myelodysplasia", N. Eng. J. Med., 340, 1649-1657.
12. Romeo, M., Chauffaille, M.L., Regina, M.R., Bahia, D.M.M. and Kerbauy, J. (2002) "Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients", Leukemia Research, 26, 993-996.
13. Mhawech, P. and Saleem, A. (2001) "Myelodysplastic syndrome: review of the cytogenetic and molecular data", Critic. Rev. Oncol/Hematol., 40, 229-238.
14. Zhao, W.L., Xu, L., Wu, W., Yan, H., Tang, W., Hu, J., et al. (2000) "The myelodysplastic syndromes: analysis of prognostic factors and comparison of prognostic systems in 128 Chinese patients from a single institution", Hematology Journal, 3, 137-144.
15. Fong, C. and Brodeur, G.M. (1987) "Down syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis", Cancer Genetic Cytogen., 28, 55-61.
16. Miller, K.B. and Daoust, P.R. (2001) Clinical manifestations of acute myeloid leukemia. In Hematology Basic Principles and Practice, 3rd edition, edited by Hoffman, R., Benz, E.J. Jr, Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L. E., McGlave, P. Pp 999-1018. New York: Churchill Livingstone.
17. Colle, I., Lacor, P., Peeters, P., Jochmans, K., De Raeve, H. and Van Camp, B. (1996) "Granulocytic sarcoma (chloroma): a report of two cases", Acta Clin. Belg., 51, 106-110.
18. Oliva, E., Ferry, J.A., Young, R.H., Prat, J., Srigley, J.R. and Scully, R.E. (1997) "Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases", Am. J. Surg. Pathol., 21, 1156-1165.